-+ 0.00%
-+ 0.00%
-+ 0.00%

KURA ONCOLOGY SHARES UP 7.5% AFTER FDA ACCEPTS MARKETING APPLICATION FOR BLOOD CANCER DRUG

Reuters·06/02/2025 13:38:16

Please log in to view news